 | Up a level |
2021
Gouni-Berthold, Ioanna, Alexander, Veronica J., Yang, Qingqing, Hurh, Eunju, Steinhagen-Thiessen, Elisabeth, Moriarty, Patrick M., Hughes, Stephen G., Gaudet, Daniel, Hegele, Robert A., O'Dea, Louis St L., Stroes, Erik S. G., Tsimikas, Sotirios and Witztum, Joseph L. (2021). Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Diabetes Endocrinol., 9 (5). S. 264 - 276. NEW YORK: ELSEVIER SCIENCE INC. ISSN 2213-8595
2020
Tsimikas, Sotirios, Karwatowska-Prokopczuk, Ewa, Gouni-Berthold, Ioanna, Tardif, Jean-Claude, Baum, Seth J., Steinhagen-Thiessen, Elizabeth, Shapiro, Michael D., Stroes, Erik S., Moriarty, Patrick M., Nordestgaard, Borge G., Xia, Shuting, Guerriero, Jonathan, Viney, Nicholas J., O'Dea, Louis and Witztum, Joseph L. (2020). Lipoprotein(a) Reduction in Persons with Cardiovascular Disease. N. Engl. J. Med., 382 (3). S. 244 - 256. WALTHAM: MASSACHUSETTS MEDICAL SOC. ISSN 1533-4406
2018
Tsimikas, Sotirios, Karwatowska-Prokopczuk, Ewa, Gouni-Berthold, Loanna, Tardif, Jean-Claude, Baum, Seth J., Steinhagen-Thiessen, Elisabeth, Shapiro, Michael D., Stroes, Erik D., Moriarty, Patrick M., Nordestgaard, Borge G., Guerriero, Jonathan, Viney, Nicholas J., O'Dea, Louis and Witztum, Joseph L. (2018). Safety and Efficacy of AKCEA-APO(a)-1 to Lower Lipoprotein(a) Levels in Patients With Established Cardiovascular Disease: A Phase 2 Dose -Ranging Trial. Circulation, 138 (25). S. E755 - 2. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1524-4539